Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Concomitant tumor immunity and the resistance to a second tumor challenge.

× No keyword cloud information.

30 in total

1. Ly 1+2- suppressor T cells down-regulate the generation of Ly 1-2+ effector T cells during progressive growth of the P815 mastocytoma.

Authors: R J North; E S Dye
Journal: Immunology Date: 1985-01 Impact factor: 7.397

2. Changes in the tumorigenic and metastatic properties of murine melanoma cells treated with a triazene derivative.

Authors: M Allegrucci; P Fuschiotti; P Puccetti; L Romani; M C Fioretti
Journal: Clin Exp Metastasis Date: 1989 May-Jun Impact factor: 5.150

3. Immunotherapy of the rat 13762SC mammary adenocarcinoma by vaccinia virus augmentation of tumor immunity.

Authors: T P Archer; P Bretscher; B Ziola
Journal: Clin Exp Metastasis Date: 1990 Nov-Dec Impact factor: 5.150

4. The therapeutic significance of concomitant antitumor immunity. I. LY-1-2+ T cells from mice with a progressive tumor can cause regression of an established tumor in gamma-irradiated recipients.

Authors: R J North
Journal: Cancer Immunol Immunother Date: 1984 Impact factor: 6.968

5. Invariant natural killer T cells regulate breast cancer response to radiation and CTLA-4 blockade.

Authors: Karsten A Pilones; Noriko Kawashima; Anne Marie Yang; James S Babb; Silvia C Formenti; Sandra Demaria
Journal: Clin Cancer Res Date: 2009-01-15 Impact factor: 12.531

6. Virus-induced hepatocellular carcinomas cause antigen-specific local tolerance.

Authors: Gerald Willimsky; Karin Schmidt; Christoph Loddenkemper; Johanna Gellermann; Thomas Blankenstein
Journal: J Clin Invest Date: 2013-02-01 Impact factor: 14.808

7. Characterization of a new spontaneously developed murine mammary adenocarcinoma in syngeneic BALB/c hosts.

Authors: T Y Chao; T M Chu
Journal: In Vitro Cell Dev Biol Date: 1989-07

8. Mechanisms of tumour rejection in the murine DBA/2-SL2 concomitant immunity system.

Authors: D Characiejus; H F Dullens; W Den Otter
Journal: Cancer Immunol Immunother Date: 1990 Impact factor: 6.968

9. Isolated soluble fractions from the murine B16 melanoma induce primary in vitro syngeneic antitumor responses.

Authors: B Y Klein; S Frenkel; D Naor
Journal: Cancer Immunol Immunother Date: 1984 Impact factor: 6.968

10. A "universal" model of metastatic cancer, its parametric forms and their identification: what can be learned from site-specific volumes of metastases.

Authors: Leonid Hanin; Karen Seidel; Dietrich Stoevesandt
Journal: J Math Biol Date: 2015-08-26 Impact factor: 2.259